 | Up a level |
Dorgalaleh, A and Tabibian, SH and Rafiee Alavi, S.E and Soori, SH and Asadi, M and Bamedi, T and Moradi, E and Shamsizadeh, M and Jalalvand, M (2016) Diagnosis, clinical manifestations and management of rare bleeding disorders in Iran. HEMATOLOGY. pp. 1-7.
Naderifar, M and Moradi, E and Hosseini, M.S and Karimipour, M and Dorgalaleh, A and Shamsizadeh, M (2016) Long Term Follow up Study on a Large Group of Patients with Congenital Factor XIII Defciency Treated Prophylactically with Fibrogammin P®. Iranian Journal of Pharmaceutical Research, 15 (2). pp. 635-640.
Naderifar, M and Karimi, M and Hosseini, M.S and Moradi, E and Shamsizadeh, M and Dorgalaleh, A (2016) Long term follow up study on a large group of patients with congenital factor XIII deficiency treated prophylactically with fibrogammin P®. Iranian Journal of Pharmaceutical Research, 15 (2). pp. 635-640.
Naderifar, M and Hosseini, M and Ahmadinejad, M and Moradi, E and Shamsizadeh, M and Dorgalaleh, A (2016) Long-term prophylaxis in patients with severe congenital factor XIII deficiency is not complicated by inhibitor formation. Blood Coagulation and Fibrinolysis, 27. pp. 1-4.
